Patients continued taking their medications for pulmonary arterial hypertension (PAH) when symptoms appeared to improve, according to a new survey. Professional guidelines say that when pulmonary ...
Whether you’re a senior in high school or a senior-living resident, you’ve likely heard of Viagra (sildenafil) — the original ...
Keros Therapeutics said on Wednesday it would voluntarily halt testing of an experimental blood pressure treatment due to ...
A month after halting dosing in two of the three treatment arms of a phase 2 trial of its pulmonary arterial hypertension ...
Keros Therapeutics has halted the dosing of its treatment for pulmonary hypertension due to adverse health effects discovered during trials. The clinical-stage biopharmaceutical company said Wednesday ...
PAH is a rare condition in children, but is often fatal if left untreated, and protocols for pediatric patients have not been ...
to treat pulmonary arterial hypertension (PAH) in the adult population. The therapy is used along with other PAH medications ...
The dosing regimen for Winrevair is optimal for balancing safety and effectiveness in adults with PAH, according to clinical ...
A body weight-adjusted regimen of Uptravi dosing for children and adolescents with PAH was deemed appropriate, according to a ...
ABU DHABI - The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the emirate, has introduced a groundbreaking medication for patients with Pulmonary Arterial ...